SERIOUS BIOAVAILABILITY PROBLEMS WITH A GENERIC PROLONGED-RELEASE QUINIDINE GLUCONATE PRODUCT

被引:11
作者
MEYER, MC
STRAUGHN, AB
LIEBERMAN, P
JACOB, J
机构
[1] UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT MED,MEMPHIS,TN 38163
[2] BERLEX LABS,CEDAR KNOLLS,NJ
关键词
D O I
10.1002/j.1552-4604.1982.tb02660.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:131 / 134
页数:4
相关论文
共 8 条
[1]   RAPID-DETERMINATION OF QUINIDINE IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ACHARI, RG ;
BALDRIDGE, JL ;
KOZIOL, TR ;
YU, L .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1978, 16 (06) :271-273
[2]   QUINIDINE PHARMACOKINETICS IN MAN - CHOICE OF A DISPOSITION MODEL AND ABSOLUTE BIOAVAILABILITY STUDIES [J].
GUENTERT, TW ;
HOLFORD, NHG ;
COATES, PE ;
UPTON, RA ;
RIEGELMAN, S .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (04) :315-330
[3]   VARIATION IN BIOLOGIC AVAILABILITY OF DIGOXIN FROM 4 PREPARATIONS [J].
LINDENBAUM, J ;
MELLOW, MH ;
BLACKSTONE, MO ;
BUTLER, VP .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (24) :1344-+
[4]  
Metzler C.M., 1974, USERS MANUAL NONLIN
[5]  
UEDA CT, 1980, APPLIED PHARM
[6]  
WAGNER JG, 1975, FUNDAMENTALS CLIN PH
[7]  
WINTER ME, 1980, BASIC CLIN PHARM
[8]  
1977, FED REG 3 0107, V42, P1624